Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole CR in Fibromyalgia
NCT00256893Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing Ropinirole CR with Placebo (2 arms). Primary endpoint: Change in pain intensity score at 12 weeks. Started Nov 2004; status: completed.
02
Drugs
ropinirole
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00256893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256893.